DaVita Kidney Care · 1 day ago
Talent Acquisition Partner, Executive
DaVita Kidney Care is a healthcare company dedicated to providing high-quality care for patients with chronic kidney failure. The Talent Acquisition Partner will play a crucial role in aligning human resources activities with the company's mission and values, while partnering with various corporate functions to drive positive business results.
Health CareHospitalMedicalNutrition
Responsibilities
Ensure PS activities are aligned with DaVita’s culture, values, and mission, executing on PS strategy to support the needs of the business
Partner with other corporate PS functions (e.g., Teammate Relations, Compensation, Benefits, Recruiting), acting as internal consultant and strategist to deliver positive business results
Ensure adherence to PS policies and compliance with Teammate Relations findings and action plans
Qualification
Required
Act as the trusted advisor on strategic human resources (HR) and other matters which impact business results
Ensure PS activities are aligned with DaVita's culture, values, and mission
Execute on PS strategy to support the needs of the business
Partner with other corporate PS functions (e.g., Teammate Relations, Compensation, Benefits, Recruiting)
Act as internal consultant and strategist to deliver positive business results
Ensure adherence to PS policies and compliance with Teammate Relations findings and action plans
Benefits
Comprehensive benefits: Medical, dental, vision, 401(k) match, paid time off, PTO cash out
Support for you and your family: Family resources, EAP counseling sessions, access Headspace®, backup child and elder care, maternity/paternity leave and more
Professional development programs: DaVita offers a variety of programs to help strong performers grow within their career and also offers on-demand virtual leadership and development courses through DaVita’s online training platform StarLearning.
Company
DaVita Kidney Care
DaVita means “to give life,” reflecting our proud history as leaders in dialysis—an essential, life-sustaining treatment for those living with end stage kidney disease (ESKD).
Funding
Current Stage
Public CompanyTotal Funding
$2.5B2025-05-20Post Ipo Debt· $750M
2024-08-08Post Ipo Debt· $1B
2021-02-24Post Ipo Debt· $750M
Recent News
EIN Presswire
2025-12-16
2025-12-11
2025-12-11
Company data provided by crunchbase